Valuation : Medicure Inc.

Market Cap 26.09M 18.86M 16.23M 15.27M 13.95M 1.78B 26.16M 180M 70.01M 914M 70.81M 69.27M 2.94B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 23.15M 16.73M 14.4M 13.54M 12.37M 1.58B 23.21M 160M 62.11M 810M 62.82M 61.45M 2.61B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+2.04%
Current month-1.96%
1 month+92.31%
3 months+131.48%
6 months+157.73%
Current year+119.30%
1 week 2.45
Extreme 2.45
2.6
1 month 1.25
Extreme 1.25
2.6
Current year 0.85
Extreme 0.85
2.6
1 year 0.85
Extreme 0.85
2.6
3 years 0.63
Extreme 0.63
2.6
5 years 0.63
Extreme 0.63
2.6
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 14/09/1997
Director of Finance/CFO 48 14/07/2011
Chief Tech/Sci/R&D Officer - 30/06/2019
Director TitleAgeSince
Chairman 79 14/09/1997
Director/Board Member 93 27/02/2000
Director/Board Member 56 21/01/2013
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Option

Chief Technology Officer

-20,000 0.1916%
28/03/25 Option

Chief Technology Officer

7,500 0.0719%
28/03/25 Option

Director

7,200 0.0690%
Change 5-day change 1-year change 3-year change Capi.($)
+2.04%0.00%+123.21%+66.67% 18.86M
-1.79%-2.27%+43.23%+88.96% 67.98B
-2.06%-0.18%+39.67%+86.44% 64.94B
-0.31%+6.54%-12.96%+378.92% 27.58B
+0.86%+1.65%-7.74%-14.95% 26.06B
-3.00%-2.90%+33.13%+12.54% 25.74B
-1.46%+0.42%+23.61%-18.61% 20.09B
-2.96%-15.21%+216.20%+368.10% 17.16B
-1.49%-4.88%-6.60%+531.89% 14.92B
-0.20%+8.37%+55.78%+164.98% 14.62B
Average -1.04%+0.23%+50.75%+166.49% 27.91B
Weighted average by Cap. -1.52%+0.18%+38.38%+137.34%

Financials

2024 2025
Net sales 21.91M 15.83M 13.63M 12.82M 11.71M 1.49B 21.97M 151M 58.78M 767M 59.46M 58.16M 2.47B 28.86M 20.86M 17.95M 16.89M 15.42M 1.97B 28.93M 200M 77.43M 1.01B 78.32M 76.61M 3.25B
Net income -1.04M -751K -646K -608K -555K -70.9M -1.04M -7.18M -2.79M -36.38M -2.82M -2.76M -117M -7.1M -5.13M -4.41M -4.15M -3.79M -484M -7.12M -49.07M -19.04M -248M -19.26M -18.84M -801M
Net Debt -6.32M -4.57M -3.93M -3.7M -3.38M -431M -6.33M -43.68M -16.95M -221M -17.15M -16.77M -713M -2.94M -2.13M -1.83M -1.72M -1.57M -201M -2.95M -20.36M -7.9M -103M -7.99M -7.82M -332M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
04/09/26 CA$2.500 +2.04% 304
03/09/26 CA$2.450 -4.67% 2,811
02/09/26 CA$2.570 +0.39% 1,300
01/09/26 CA$2.560 +0.39% 1,000
31/08/26 CA$2.550 +2.00% 10,238